Physician profile
Mindi Hamby
NPI 1306827605
$13,431.91
in general payments reported to CMS, 2019-2025
55 companies · $1,988 in 2025
The $1,988 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $1,604 · 2021: $2,181 · 2022: $2,124 · 2023: $2,346 · 2024: $2,026 · 2025: $1,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,359.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,174.56 | 2020-2025 | |
| Novo Nordisk INC | $1,720.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,209.35 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $1,066.15 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $890.88 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $684.89 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $457.83 | 2021-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $441.46 | 2019-2023 | Spravato |
| Teva Pharmaceuticals USA, INC. | $395.24 | 2019-2023 | Austedo |
| Lilly USA, LLC | $321.37 | 2020-2025 | Jardiance, Kisunla, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $314.30 | 2019-2025 | Xifaxan, Trulance |
| Corcept Therapeutics | $311.54 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company Ltd. | $283.49 | 2022 | |
| Allergan, INC. | $273.31 | 2019-2020 | |
| Exact Sciences Corporation | $266.36 | 2023-2025 | Cologuard Collection Kit |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindi Hamby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.